Pricing
  1. US-listed companies
  2. Panbela Therapeutics, Inc.
  3. Financials
  4. Net income

Panbela Therapeutics, Inc.【PBLA】

Market cap
$63.36K
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2023-25-27.51%
Dec 31, 2022-35+245.54%
Dec 31, 2021-10+111.83%
Dec 31, 2020-5-23.10%
Dec 31, 2019-6-117.66%
Dec 31, 201835-438.35%
Dec 31, 2017-10+102.93%
Dec 31, 2016-5+3.75%
Dec 31, 2015-5+4502.78%
Dec 31, 2014-0-49.51%
Dec 31, 2013-0-185.71%
Dec 31, 20120

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)